[Multiple myeloma in patients under 40 years of age].
Clinical course of multiple myeloma in patients under 40 years of age was analysed. In all cases diagnosis was established in III stage of the disease according to Durie and Salmon. In 4 cases good response to treatment (partial remission or stabilisation of proliferative process) was achieved. Survival time of 2 dead patients was 5 and 74 months, and that of 3 still alive patients is 41, 53, and 59 months and tends to be longer than median survival time of general population of patients with multiple myeloma.
Wróbel
T
T
Kliniki Hematologii i Chorób Rozrostowych AM we Wrocławiu.
D000328:Adult; D018572:Disease-Free Survival; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000628:therapy; D009367:Neoplasm Staging; D012074:Remission Induction
Szpiczak plazmocytowy u osób ponizej 40 roku zycia.